Prot #202301032: ADI-PEG 20 in Combination with Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-Small Cell and Small Cell Lung Cancers

Project: Research project

Project Details

StatusActive
Effective start/end date3/5/253/5/28

Funding

  • Washington University in St. Louis (Prot #202301032 // Prot #202301032)
  • Polaris Pharmaceuticals, Inc. (Prot #202301032 // Prot #202301032)